AADi Bioscience, Inc. – Trademark Portfolio

Entity Type: 03

AADi Bioscience, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include FYARRO. The owner is based in Pacific Palisades, CA.

1343 Luna Vista Dr

Pacific Palisades, CA 90272

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AADi Bioscience, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (13 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (9 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does AADi Bioscience, Inc. have?

AADi Bioscience, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending, 9 abandoned.

What trademark classes does AADi Bioscience, Inc. file in?

AADi Bioscience, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AADi Bioscience, Inc.'s most well-known trademarks?

AADi Bioscience, Inc.'s registered trademark portfolio includes well-known marks such as FYARRO. These are among 1 currently registered trademark in the portfolio.

What is AADi Bioscience, Inc.'s trademark registration success rate?

AADi Bioscience, Inc. has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 3 applications are pending review.